Mechanism of toxicity and rationale for use of the combination of pentazocine and pyribenzamine in morphine-dependent subjects.
D000818:Animals; D001831:Body Temperature / Q000187:drug effects; D001835:Body Weight / Q000187:drug effects; D004305:Dose-Response Relationship, Drug; D006801:Humans; D007928:Lethal Dose 50; D008297:Male; D051379:Mice; D009021:Morphine Dependence / Q000503:physiopathology*; D009043:Motor Activity / Q000187:drug effects; D009270:Naloxone / Q000494:pharmacology; D010423:Pentazocine / Q000008:administration & dosage / Q000633:toxicity*; D013375:Substance Withdrawal Syndrome / Q000139:chemically induced; D014309:Tripelennamine / Q000008:administration & dosage / Q000633:toxicity*
D009270:Naloxone; D014309:Tripelennamine; D010423:Pentazocine